Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
October 6, 2016
October 4, 2016
October 3, 2016
September 29, 2016
September 29, 2016
September 26, 2016
September 22, 2016
September 20, 2016
September 19, 2016
September 15, 2016
September 12, 2016
September 8, 2016
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community